![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | A61K 38/48 | |
A61P 7/04 |
(11) | Patento numeris | 1761274 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 05756838.8 |
Europos patento paraiškos padavimo data | 2005-06-21 | |
(97) | Europos patento paraiškos paskelbimo data | 2007-03-14 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2009-09-02 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/EP2005/052890 |
Data | 2005-06-21 |
(87) | Numeris | WO 2005/123118 |
Data | 2005-12-29 |
(30) | Numeris | Data | Šalis |
200400972 | 2004-06-21 | DK | |
200400981 | 2004-06-23 | DK |
(72) |
BRUN, Nikolai Constantin, DK
ERHARDTSEN, Elisabeth, DK
SKOLNICK, Brett E., US
|
(73) |
Novo Nordisk Health Care AG,
Andreasstrasse 15, 8050 Zürich,
CH
|
(54) | FACTOR VIIA OR FACTOR VIIA EQUIVALENTS FOR PREVENTING OR ATTENTUATING HAEMORRHAGE GROWTH, AND/OR OEDEMA GENERATION FOLLOWING INTRACEREBRAL HAEMORRHAGE (ICH) |
FACTOR VIIA OR FACTOR VIIA EQUIVALENTS FOR PREVENTING OR ATTENTUATING HAEMORRHAGE GROWTH, AND/OR OEDEMA GENERATION FOLLOWING INTRACEREBRAL HAEMORRHAGE (ICH) |